ARVO 2022
Connect with One of Our Experts
- Laszlo Bekesi, MD MSc MBA Ophthalmologist,
Vice President Therapeutic Strategy and Innovation Neuroscience Group - Lori Helgeson, CPOT, ABOC, NCLC Executive Director,
Ophthalmology Clinical Development - Michael Botuchis, Senior Director, Business Development
- Forest Flodin, Senior Director, Business Development
- Alex Padgett, Associate Director, Business Development
- Whitney Shankland, Senior Director, Business Development
We collaborate to restore vision and improve lives
Syneos Health has supported the development and commercialization of nearly 50 approved therapies for eye disorders, making us the leading provider of product development services for drug, device and diagnostics in vision care.
We always start with the end in mind
At Syneos Health, our unique lab-to-life service offering is purpose-built to provide you with integrated scientific, clinical, regulatory, commercialization and marketing expertise.
We bring commercial insights forward into clinical development with teams that combine traditional functions (i.e., project managers, medical monitors, CRAs and therapeutic and functional experts) with specialists in market access, study branding and patient engagement/advocacy, medical science liaisons and nurse educators.
Want to learn more? Explore Insights Hub for the latest industry perspectives, subscribe to our podcast, or click on the resources below:
Conducting Ophthalmology Clinical Trials During a Pandemic Outbreak
